VERONA PHARMA PLC - ADR (VRNA) Stock Earnings & Estimates
USA - NASDAQ:VRNA - US9250501064 - ADR
106.79 USD
-0.03 (-0.03%)
106.79 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 460K -98.85% | -100.00% | 42.279M | 427M 909.96% | 753.54M 76.47% | 1.159B 53.81% | 1.623B 40.03% | 2.144B 32.10% | 2.678B 24.91% | 3.206B 19.72% | 3.686B 14.97% | |
| EBITDA YoY % growth | -75.11M -3.34% | -66.892M 10.94% | -153.569M -129.58% | 41.004M 126.70% | 715.73M 1,645.51% | 1.356B 89.46% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -75.75M -3.33% | -67.569M 10.80% | -154.627M -128.84% | 40.418M 126.14% | 263.52M 551.99% | 625.73M 137.45% | 958.81M 53.23% | 1.362B 42.05% | 1.8B 32.16% | 2.208B 22.67% | 2.595B 17.53% | |
| Operating Margin | -16,467.39% | N/A | -365.73% | 9.47% | 34.97% | 53.99% | 59.08% | 63.53% | 67.21% | 68.87% | 70.40% | |
| EPS YoY % growth | -1.11 -14.43% | -0.68 38.74% | -2.16 -217.65% | 0.52 123.97% | 2.20 325.94% | 5.25 138.01% | 10.44 99.03% | 16.76 60.45% | 22.22 32.56% | 28.04 26.22% | 34.24 22.12% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.27 147.36% | 0.19 147.60% | 0.39 346.08% | 0.66 406.08% | 0.82 210.58% | 0.88 360.71% |
| Revenue Q2Q % growth | 123.03M 2,087.59% | 130.79M 256.81% | 149.36M 95.87% | 171.53M 66.31% | 196.44M 59.67% | 233.64M 78.64% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 26.32M 164.72% | 21.884M 219.33% | 46.539M 551.09% | 53.386M 1,050.56% | 86.063M 226.99% | 119.24M 444.87% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.13 114.77% | 0.05 | 0.08 | 154.90% |
| Q1 2025 Q2Q % growth | -0.16 50.00% | -0.15 | -0.01 | -4.58% |
| Q4 2024 Q2Q % growth | -0.40 -122.22% | -0.30 | -0.10 | -34.07% |
| Q3 2024 Q2Q % growth | -0.56 -211.11% | -0.51 | -0.05 | -9.80% |
| Q2 2024 Q2Q % growth | -0.88 -1,000.00% | -0.30 | -0.58 | -192.46% |
| Q1 2024 Q2Q % growth | -0.32 -33.33% | -0.17 | -0.15 | -91.30% |
| Q4 2023 Q2Q % growth | -0.18 -12.50% | -0.27 | 0.09 | 32.13% |
| Q3 2023 Q2Q % growth | -0.18 21.74% | -0.29 | 0.11 | 36.97% |
| Q2 2023 Q2Q % growth | -0.08 75.00% | -0.30 | 0.22 | 73.19% |
| Q1 2023 Q2Q % growth | -0.24 40.00% | -0.19 | -0.05 | -23.84% |
| Q4 2022 Q2Q % growth | -0.16 60.00% | -0.10 | -0.06 | -53.04% |
| Q3 2022 Q2Q % growth | -0.23 -243.75% | -0.17 | -0.06 | -37.49% |
| Q2 2022 Q2Q % growth | -0.32 13.51% | -0.39 | 0.07 | 16.89% |
| Q1 2022 Q2Q % growth | -0.40 -11.11% | -0.45 | 0.05 | 10.87% |
| Q4 2021 Q2Q % growth | -0.40 | -0.49 | 0.09 | 19.14% |
| Q3 2021 Q2Q % growth | 0.16 134.78% | -0.37 | 0.53 | 143.57% |
| Q2 2021 Q2Q % growth | -0.37 43.94% | -0.45 | 0.08 | 17.18% |
| Q1 2021 Q2Q % growth | -0.36 62.11% | -0.48 | 0.12 | 25.51% |
| Q4 2020 Q2Q % growth | -0.40 45.21% | -0.36 | -0.04 | -12.04% |
| Q3 2020 Q2Q % growth | -0.46 51.37% | -0.22 | -0.24 | -108.14% |
| Q2 2020 Q2Q % growth | -0.66 24.14% | -0.48 | -0.18 | -36.70% |
| Q1 2020 Q2Q % growth | -0.95 -77.24% | -0.67 | -0.28 | -42.56% |
| Q4 2019 Q2Q % growth | -0.73 | -1.12 | 0.39 | 34.64% |
| Q3 2019 Q2Q % growth | -0.95 | -0.81 | -0.14 | -16.66% |
| Q2 2019 Q2Q % growth | -0.87 | -0.77 | -0.10 | -13.35% |
| Q1 2019 Q2Q % growth | -0.54 | -0.50 | -0.03 | -6.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 103.138M | 93.991M | 9.147M | 9.73% |
| Q1 2025 Q2Q % growth | 76.256M | 54.437M | 21.819M | 40.08% |
| Q4 2024 Q2Q % growth | 36.655M | 33.712M | 2.943M | 8.73% |
| Q3 2024 Q2Q % growth | 5.624M | 2.055M | 3.569M | 173.67% |
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 460K | 3.643M | -3.183M | -87.37% |
| Q3 2022 Q2Q % growth | -100.00% | 3.643M | -3.643M | -100.00% |
| Q3 2021 Q2Q % growth | 40M | 4.25M | 35.75M | 841.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2894.01% | 2.01% | 915% |
| Revenue | 0% | 1.04% | 1.34% | 1.83% |